These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 15776373

  • 1. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
    Orscheln RC, Johnson DR, Olson SM, Presti RM, Martin JM, Kaplan EL, Storch GA.
    J Infect Dis; 2005 Apr 15; 191(8):1272-9. PubMed ID: 15776373
    [Abstract] [Full Text] [Related]

  • 2. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H.
    J Antimicrob Chemother; 2009 May 15; 63(5):886-94. PubMed ID: 19279051
    [Abstract] [Full Text] [Related]

  • 3. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
    Billal DS, Fedorko DP, Yan SS, Hotomi M, Fujihara K, Nelson N, Yamanaka N.
    J Antimicrob Chemother; 2007 Jan 15; 59(1):28-34. PubMed ID: 17065188
    [Abstract] [Full Text] [Related]

  • 4. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
    Smeesters PR, Vergison A, Junior DC, Van Melderen L.
    Int J Antimicrob Agents; 2009 Jul 15; 34(1):44-9. PubMed ID: 19269141
    [Abstract] [Full Text] [Related]

  • 5. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10.
    Van Heirstraeten L, Leten G, Lammens C, Goossens H, Malhotra-Kumar S.
    J Antimicrob Chemother; 2012 Nov 15; 67(11):2602-5. PubMed ID: 22815354
    [Abstract] [Full Text] [Related]

  • 6. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.
    Arai K, Hirakata Y, Yano H, Kanamori H, Endo S, Hirotani A, Abe Y, Nagasawa M, Kitagawa M, Aoyagi T, Hatta M, Yamada M, Nishimaki K, Takayama Y, Yamamoto N, Kunishima H, Kaku M.
    J Antimicrob Chemother; 2011 Mar 15; 66(3):494-8. PubMed ID: 21172783
    [Abstract] [Full Text] [Related]

  • 7. Fluoroquinolone resistance in Streptococcus pyogenes.
    Richter SS, Diekema DJ, Heilmann KP, Almer LS, Shortridge VD, Zeitler R, Flamm RK, Doern GV.
    Clin Infect Dis; 2003 Feb 01; 36(3):380-3. PubMed ID: 12539083
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
    Reinert RR, Lütticken R, Al-Lahham A.
    Clin Microbiol Infect; 2004 Jul 01; 10(7):659-62. PubMed ID: 15214881
    [Abstract] [Full Text] [Related]

  • 11. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
    Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J, Martín R, Liñares J.
    J Antimicrob Chemother; 2010 Apr 01; 65(4):634-43. PubMed ID: 20118164
    [Abstract] [Full Text] [Related]

  • 12. Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes.
    Malhotra-Kumar S, Lammens C, Chapelle S, Mallentjer C, Weyler J, Goossens H.
    J Antimicrob Chemother; 2005 Mar 01; 55(3):320-5. PubMed ID: 15705642
    [Abstract] [Full Text] [Related]

  • 13. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
    Rivera A, Rebollo M, Sánchez F, Navarro F, Miró E, Mirelis B, Coll P.
    Clin Microbiol Infect; 2005 Sep 01; 11(9):759-61. PubMed ID: 16104992
    [Abstract] [Full Text] [Related]

  • 14. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
    Schurek KN, Adam HJ, Siemens CG, Hoban CJ, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2005 Oct 01; 56(4):769-72. PubMed ID: 16126779
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ, Toleman MA, Walsh TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Jun 01; 55(2):119-27. PubMed ID: 16530373
    [Abstract] [Full Text] [Related]

  • 19. Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes.
    Alonso R, Mateo E, Galimand M, Garaizar J, Courvalin P, Cisterna R.
    J Clin Microbiol; 2005 May 01; 43(5):2492-3. PubMed ID: 15872292
    [Abstract] [Full Text] [Related]

  • 20. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012.
    Wajima T, Morozumi M, Chiba N, Shouji M, Iwata S, Sakata H, Ubukata K.
    Int J Antimicrob Agents; 2013 Nov 01; 42(5):447-9. PubMed ID: 23988719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.